Terns Pharmaceuticals, Inc. (NASDAQ:TERN) CFO Purchases $39,300.00 in Stock
MarketBeat
Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) CFO Andrew Gengos bought 10,000 shares of the business's stock in a transaction on Friday, June 27th. The stock was purchased at an average price of $3.93 per share, for a total transaction of $39,300.00. Following the purchase, the chief financial officer directly owned 25,000 shares in the company, valued at approximately $98,250. This represents a 66.67% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.
NASDAQ:TERN